Molbio Diagnostics
Latest news, explainers and analysis on Molbio Diagnostics. Tracking 7 stories on Arth Vani.
Connected in the graph
Latest on Molbio Diagnostics
IPOBreakingMolbio Diagnostics Surges 83% Since Listing: Motilal Oswal Issues 'Buy' Rating
Molbio Diagnostics has delivered massive returns of over 80% within two months of its stock market debut. Brokerage firm Motilal Oswal remains bullish on the stock, citing strong growth potential despite the recent price rally.
IPOBreakingMolbio Diagnostics IPO Subscribed 17.37 Times on Day 3; GMP at ₹138
The Molbio Diagnostics IPO has seen strong investor interest, being subscribed 17.37 times by the end of Day 3. The grey market premium (GMP) for the shares is currently ₹138, indicating potential listing gains.
IPOBreaking5 IPOs Raise ₹7,000 Cr: Dhoot, Molbio Top Picks This Week
Five companies are set to raise over ₹7,000 crore through IPOs this week. Analysts are favouring Dhoot Transmission and Molbio Diagnostics, with Milky Mist Dairy Food also seen as a stable bet.
IPOBreakingMolbio Diagnostics Plans ₹940 Crore IPO, Includes ₹200 Crore Fresh Issue for Capex
Molbio Diagnostics is set to launch an Initial Public Offering (IPO) to raise a total of ₹940 crore. The IPO comprises a fresh issuance of shares worth ₹200 crore, earmarked for capital expenditures, and an offer for sale (OFS) of ₹740 crore by promoters. The company, known for its tuberculosis diagnostic kits, operates globally across more than ninety countries.
IPOBreakingMolbio Diagnostics IPO Opens: ₹904 Cr Issue, Anchor Investors Commit ₹281 Cr
Molbio Diagnostics' Initial Public Offering (IPO) opened for subscription today, August 10, aiming to raise between ₹904 crore and ₹940 crore. The company has already secured ₹281.5 crore from anchor investors, signalling strong institutional interest.
IPOBreakingMolbio Diagnostics Raises ₹281 Crore From Anchor Investors Ahead of IPO Launch
Goa-based Molbio Diagnostics has secured ₹281.5 crore from institutional anchor investors as it prepares for its public market debut. The company plans to raise up to ₹940 crore to fund manufacturing expansion and infrastructure upgrades.
IPOBreakingMolbio Diagnostics IPO: Price Band ₹768-₹807, Opens Aug 10
Molbio Diagnostics has announced its Initial Public Offering (IPO) with a price band set between ₹768 and ₹807 per share. The subscription period will be open from August 10 to August 12.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.